A. Stege
Impact in
-
- Drug Transport and Resistance Mechanisms
-
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- DNA and Nucleic Acid Chemistry
- Cancer therapeutics and mechanisms
Papers in
-
- RNA Interference and Gene Delivery 7
- Advanced biosensing and bioanalysis techniques 5
- Glycosylation and Glycoproteins Research 1
- Oncology 6
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Hermann Lage (8 shared papers)Verena Materna (2 shared papers)Paweł Surowiak (2 shared papers)Ulrike Stein (2 shared papers)Iduna Fichtner (2 shared papers)Wolfgang Walther (2 shared papers)Per Sonne Holm (1 shared paper)Yutaka Midorikawa (1 shared paper)
- Journals
- Molecular Therapy (1 paper)Biochemical and Biophysical Research Communications (1 paper)Oncogene (1 paper)Scientific Reports (1 paper)Cancer Gene Therapy (1 paper)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
A. Stege
10 papers receiving 398 citations
Peers
Comparison fields: 5 of 57
- Oncology 183
- Molecular Biology 283
- Cancer Research 48
- Biomaterials 29
- Genetics 48
Countries citing papers authored by A. Stege
This map shows the geographic impact of A. Stege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Stege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Stege more than expected).
Fields of papers citing papers by A. Stege
This network shows the impact of papers produced by A. Stege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Stege. The network helps show where A. Stege may publish in the future.
Co-authors
The 21 scholars most cited alongside A. Stege, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 169 | |
| 2 | 2004 | 66 | |
| 3 | 2007 | 53 | |
| 4 | 2006 | 43 | |
| 5 | 2003 | 31 | |
| 6 | 2006 | 23 | |
| 7 | 2009 | 17 | |
| 8 | 2008 | 9 | |
| 9 | In vivo reversal of the multidrug resistance (MDR) phenotype in a multidrug resistant cancer model by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA | 2007 | 5 |
| 10 | 2018 | 1 | |
| 11 | 2024 | 0 |
About A. Stege
A. Stege is a scholar working on Molecular Biology, Oncology, Surgery, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 11 papers that have together received 417 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), Medical and Health Sciences Research (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), COVID-19 Clinical Research Studies (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Proteoglycans and glycosaminoglycans research (1 paper). The work is most often cited by research in Oncology (183 citations), Molecular Biology (283 citations), Cancer Research (48 citations), Biomaterials (29 citations) and Genetics (48 citations). A. Stege has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Hermann Lage, Verena Materna, Paweł Surowiak, Ulrike Stein, Iduna Fichtner, Wolfgang Walther, Per Sonne Holm, Yutaka Midorikawa, Michael Hummel and Holger Tönnies. Their work appears in journals such as Molecular Therapy, Biochemical and Biophysical Research Communications, Oncogene, Scientific Reports and Cancer Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.